Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract

References

• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting. Airlie House, Virginia, November, 1997. J Clin Oncol, 17: 3835–3849
   Google Scholar
• Jaffe E S, Chan J K, Su I J, Frizzera G, Mori S, Feller A C, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20: 103–111
   PubMed Web of Science ®Google Scholar
• Cheung M M, Chan J K, Wong K F. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 2003; 40: 221–232
   PubMed Web of Science ®Google Scholar
• Ribrag V, Ell Hajj M, Janot F, Girinsky T, Domenge C, Schwaab G, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001; 15: 1123–1126
   PubMed Web of Science ®Google Scholar
• Chen H H, Fong L, Su I J, Ting L L, Hong R L, Leung H W, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 1996; 38: 1–6
   PubMed Web of Science ®Google Scholar
• Sobrevilla-Calvo P, Meneses A, Alfaro P, Bares J P, Amador J, Reynoso E E, et al. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol 1993; 32: 69–72
   PubMed Web of Science ®Google Scholar
• Aviles A, Diaz N R, Neri N, Cleto S, Talawera A. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol 2000; 22: 215–220
   PubMedGoogle Scholar
• Logsdon M D, Ha C S, Kavadi V S, Cabanillas F, Hess M A, Cox J D, et al. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 1997; 80: 477–488
   PubMed Web of Science ®Google Scholar
• Kim G E, Cho J H, Yang W I, Chung E J, Suh C O, Park K R, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54–63
   PubMed Web of Science ®Google Scholar
• Kim W S, Song S Y, Ahn Y C, Ko Y H, Baek C H, Kim D Y, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma. Ann Oncol 2001; 12: 349–352
   PubMed Web of Science ®Google Scholar
• Li Y X, Coucke P A, Li J Y, Gu D Z, Liu X F, Zhou L Q, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 1998; 83: 449–456
   PubMed Web of Science ®Google Scholar
• Kwong Y L, Chan A C, Liang R, Chiang A K, Chim C S, Chan T K, et al. CD56 + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997; 97: 821–829
   PubMed Web of Science ®Google Scholar
• Shikama N, Izuno I, Oguchi M, Gomi K, Sone S, Takei K, et al. Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. Radiology 1997; 204: 467–470
   PubMed Web of Science ®Google Scholar
• Hirakawa S, Kuyama M, Takahashi S, Yamasaki O, Kanzaki H, Teshima T, et al. Nasal and nasal-type natural killer/T-cell lymphoma. J Am Acad Dermatol 1999; 40: 268–272
   PubMed Web of Science ®Google Scholar
• You J Y, Chi K H, Yang M H, Chen C C, Ho C H, Chau W K, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 2004; 15: 618–625
   PubMed Web of Science ®Google Scholar
• Cheung M M, Chan J K, Lau W H, Ngan R K, Foo W W. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182–190
   PubMed Web of Science ®Google Scholar
• Kim T M, Park Y H, Lee S Y, Kim J H, Kim D W, Im S A, et al. Local tumor invasiveness is more predictive of survival than international prognostic index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type. Blood 2005; 106: 3785–3790
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Krenacs L, Kumar S, Kingma D W, Raffeld M. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 1999; 111: S46–55
   PubMed Web of Science ®Google Scholar
• Lee J, Park Y H, Kim W S, Lee S S, Ryoo B Y, Yang S H, et al. Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402–1408
   PubMed Web of Science ®Google Scholar
• Lee J, Kim W S, Park Y H, Park S H, Park K W, Kang J H, et al. Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 2005; 92: 1226–1230
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Chim C S, Ma S Y, Au W Y, Choy C, Lie A K, Liang R, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004; 103: 216–221
   PubMed Web of Science ®Google Scholar
• Kim G E, Lee S W, Chang S K, Park H C, Pyo H R, Kim J H, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001; 61: 261–269
   PubMed Web of Science ®Google Scholar
• Kim B S, Kim T Y, Kim C W, Kim J Y, Heo D S, Bang Y J, et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy – result of chemotherapy in NK/T-cell lymphoma. Acta Oncol 2003; 42: 779–783
   PubMed Web of Science ®Google Scholar
• Kim K, Chie E K, Kim C W, Kim I H, Park C I. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol 2005; 35: 1–5
   PubMed Web of Science ®Google Scholar
• Drenou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, et al. CD3− CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997; 89: 2966–2974
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995; 76: 2351–2356
   PubMed Web of Science ®Google Scholar